Drug intelligence / Profile preview

4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

**Description:** 4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid is a synthetic small molecule with the molecular formula C20H20Cl2N2O5 and a molecular weight of approximately 439.29 g/mol[1][2][5]. It is structurally related to phenoxy butyric acids and contains both dichlorobenzoyl and ureido functional groups. The compound has been referenced in chemical databases such as PubChem (CID:5326886), ChemSpider (ID:4484178), and DrugBank[1][5]. Mechanistically or pharmacologically relevant information about its clinical use or therapeutic indication is not available in public drug databases; it appears to be an experimental compound. There are no known brand names or marketed formulations for this substance.

Other names
4-(4-{[(2,4-Dichlorbenzoyl)carbamoyl]amino}-2,3-dimethylphenoxy)butanoic acidAcide 4-(4-{[(2,4-dichlorobenzoyl)carbamoyl]amino}-2,3-diméthylphénoxy)butanoïque
02

Targets

PYG (Glycogen phosphorylase)

Beyond the preview

Go deeper on 4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-{4-[3-(2,4-dichloro-benzoyl)-ureido]-2,3-dimethyl-phenoxy}-butyric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call